Simcere is a new-type pharmaceutical group integrating production, R&D and sales. For many consecutive years, it has been rated as one of the “Top 10 Innovative Pharmaceutical Enterprises” by authoritative media in the industry. The company has more than 50 product portfolios. To date, it has filed more than 200 domestic and PCT patent applications, and more than 10 innovative drugs it produced have entered the clinical research stage.